$23.51
1.30% day before yesterday
NYSE, Jan 02, 10:00 pm CET
ISIN
US3580291066
Symbol
FMS

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock price

$23.51
-0.22 0.93% 1M
-4.81 16.98% 6M
-0.31 1.30% YTD
+1.36 6.14% 1Y
+7.17 43.88% 3Y
-19.04 44.75% 5Y
-17.77 43.05% 10Y
+14.75 168.46% 20Y
NYSE, Closing price Fri, Jan 02 2026
-0.31 1.30%

New AI Insights on Fresenius Medical Care AG & Co. KGaA Sponsored ADR Insights AI Insights on Fresenius Medical Care AG & Co. KGaA Sponsored ADR

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$13.9b
Enterprise Value
$24.0b
Net debt
$10.2b
Cash
$2.1b
Shares outstanding
289.9m
Valuation (TTM | estimate)
P/E
8.2 | 5.1
P/S
0.6 | 0.6
EV/Sales
1.0 | 1.0
EV/FCF
11.7
P/B
0.9
Dividends
DPS
$0.81
Yield 1Y | 5Y
3.5% | 2.8%
Growth 1Y | 5Y
26.8% | 2.6%
Payout 1Y | 3Y
29.9% | 28.6%
Increased
2 Years
Financials (TTM | estimate)
Revenue
$23.0b | $23.2b
EBITDA
$3.5b | $4.2b
EBIT
$1.7b | $2.4b
Net Income
$842.2m | $1.3b
Free Cash Flow
$2.1b
Growth (TTM | estimate)
Revenue
2.1% | 2.1%
EBITDA
-4.4% | 19.0%
EBIT
-3.4% | 64.4%
Net Income
9.0% | 113.2%
Free Cash Flow
14.5%
Margin (TTM | estimate)
Gross
25.0%
EBITDA
15.4% | 18.1%
EBIT
7.2%
Net
3.7% | 5.8%
Free Cash Flow
8.9%
Financial Health
Equity Ratio
43.4%
Return on Equity
3.7%
ROCE
5.6%
ROIC
4.4%
Debt/Equity
0.8
More
EPS
$2.9
FCF per Share
$7.1
Short interest
0.2%
Employees
112k
Rev per Employee
$200.0k
Show more

Is Fresenius Medical Care AG & Co. KGaA Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

7x Buy
24%
11x Hold
38%
11x Sell
38%

Analyst Opinions

29 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

Buy
24%
Hold
38%
Sell
38%

Financial data from Fresenius Medical Care AG & Co. KGaA Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
23,033 23,033
2% 2%
100%
- Direct Costs 17,275 17,275
2% 2%
75%
5,759 5,759
2% 2%
25%
- Selling and Administrative Expenses 3,621 3,621
2% 2%
16%
- Research and Development Expense 199 199
15% 15%
1%
3,537 3,537
4% 4%
15%
- Depreciation and Amortization 1,881 1,881
5% 5%
8%
EBIT (Operating Income) EBIT 1,657 1,657
3% 3%
7%
Net Profit 842 842
9% 9%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Fresenius Medical Care AG & Co. KGaA Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock News

Neutral
PRNewsWire
24 days ago
Effective January 1, 2026, Charles Hugh-Jones will join the Management Board as Global Chief Medical Officer As part of a planned transition Franklin W. Maddux will retire by year end BAD HOMBURG, Germany , Dec. 10, 2025 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal disease, has appointed Charles...
Positive
Seeking Alpha
about one month ago
Fresenius Medical Care (FMS) is rated a 'Buy,' citing strong fundamentals. FMS demonstrates robust revenue growth, margin expansion, and dividend safety, with a new HVHDF product rollout expected to drive future upside. Despite market concerns over GLP-1 drugs and recent share declines, FMS is positioned for double-digit EPS growth and offers a well-covered 3-4% yield.
Neutral
Seeking Alpha
about 2 months ago
Fresenius Medical Care AG ( FMS ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Dominik Heger - Executive VP and Head of Investor Relations, Strategic Development & Communications Helen Giza - Chair of Management Board & CEO Martin Fischer - CFO & Member of the Management Board Conference Call Participants Oliver Metzger - ODDO BHF Corporate & Markets, Research Divisio...
More Fresenius Medical Care AG & Co. KGaA Sponsored ADR News

Company Profile

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Head office Germany
CEO Helen Giza
Employees 111,513
Founded 1996
Website www.freseniusmedicalcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today